Data from Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
Corey Smith(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Denis J. Moss(The University of Queensland), William B. Coman(The University of Queensland), Victor Lee(University of Ottawa), Vivian Li(Queen Mary Hospital), Daniel Chua, Kwok Hung Chan(University of Hong Kong), Dora L.�W. Kwong(University of Hong Kong), Leone Beagley, Janice Tsang(The University of Queensland), John M. Nicholls(University of Hong Kong)
Cited by 0
Related Papers
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
|Cell stem cell|2018|723
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
|Journal of Clinical Virology|2004|541
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
|Radiotherapy and Oncology|2017|374
Detection of SARS Coronavirus in Patients with Suspected SARS
|Emerging infectious diseases|2004|323